T. Rowe Price Investment Management, Inc. Certara, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.36 - $18.94 $2.03 Million - $2.88 Million	152,132 Added 4.75%	3,354,430 $46.5 Million
Q1 2024 May 15, 2024	BUY	$15.65 - $19.45 $11.2 Million - $13.9 Million	712,902 Added 28.64%	3,202,298 $57.3 Million
Q4 2023 Feb 14, 2024	SELL	$12.12 - $18.19 $9 Million - $13.5 Million	-742,562 Reduced 22.98%	2,489,396 $43.8 Million
Q3 2023 Nov 14, 2023	SELL	$13.9 - $19.58 $1.17 Million - $1.65 Million	-84,412 Reduced 2.55%	3,231,958 $47 Million
Q2 2023 Aug 14, 2023	BUY	$16.89 - $24.64 $206,750 - $301,618	12,241 Added 0.37%	3,316,370 $60.4 Million
Q1 2023 May 15, 2023	BUY	$15.9 - $24.72 $25.5 Million - $39.7 Million	1,605,636 Added 94.53%	3,304,129 $79.7 Million
Q4 2022 Feb 14, 2023	BUY	$10.7 - $17.84 $2.62 Million - $4.36 Million	244,529 Added 16.82%	1,698,493 $27.3 Million
Q3 2022 Nov 14, 2022	BUY	$12.84 - $24.13 $18.7 Million - $35.1 Million	1,453,964 New	1,453,964 $19.3 Million

234

106M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.75B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.